Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung Function

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who can perform lung function tests and who can produce sputum (\> 5 years of age)~* (Fe)males between 6-64 years~Exclusion Criteria:~* Patients on the waiting lists for lung transplant.~* Pregnancy or breast feeding~* Patients can not take part in another 'inhalation'trial for Cystic Fibrosis

- Gender: ALL
- Minimum Age: 6 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Acetylcysteine (Type: EXPERIMENTAL): Inhalation with N-Acetylcysteine
- normal saline (Type: PLACEBO_COMPARATOR): Inhalation with normal saline solution

Based on this trial design, predict the completion outcome and termination type (if applicable).